go to contents

EURRUS Biotech GmbH

Back to list

Facts

Founded
2006
Staff
2
Organization type
RDM biotech/pharma
Region
Lower Austria
Focus
human health

Profile

EURRUS Biotech GmbH ("Eurrus") is incorporated in Tulln, Austria. Founded in 2006 the existing partners joined in 2012. Development focus is Asthma with a newly developed API. Development status has reached CP IIb.

R&D:Medical indication: Eosinophilic Asthma Bronchial EURRUS BIOTECH GMBH is granted a worldwide and unlimited development and exploitation patent license from Pharmenterprise LLC for XC-8 including patent utilization/sale with the exception of Russia and CIS. The target for this project is the clinical development up to Phase IIb and outlicencing to strategic partners in 2021/2022. CP IIb is expected to be finished in 2021.

Similar companies in RDM biotech/pharma

ENSEMO GmbH

Organization type
RDM biotech/pharma
Region
Lower Austria
Details

Allcyte GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Mark53 GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

AMGEN GMBH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Contact

Technopark 1, Gebäude C
3430 Tulln
Lower Austria

Contact: Helmut Schmutz (CEO)
Email: info@eurrus.at
Website